Sign In to Request a Protocol
Sign In to Request a Protocol

5-Amino-1MQ (10 mg Vial) Research Protocol

  • Table of Contents

5-Amino-1MQ Research Reference

5-Amino-1MQ research information is provided for educational and laboratory reference purposes. A 10 mg vial format may be referenced with concentration information for research documentation. This information is intended for research reference only and does not provide instructions for human use.

  • Research Reference: Concentration information is provided for educational and laboratory documentation purposes.
  • Research Documentation: Available information may be referenced when documenting laboratory research details and study materials.
  • Research Information : 5-Amino-1MQ research data is provided for reference regarding NNMT pathways and related cellular research processes.
  • Storage Reference : Lyophilized material should be stored according to stability requirements and recommended handling procedures.

5-Amino-1MQ is a selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied in research settings for its interaction with cellular metabolic pathways. Research has investigated NNMT activity and its relationship with nicotinamide metabolism and related cellular processes. This educational information provides research reference details for the 10 mg vial format.

  • Dosing & Reconstitution Guide
Subcutaneous, once or twice daily

Subcutaneous Protocol (2 mL = 5 mg/mL)

PhaseDaily Dose (mg)Units (per injection) (mL)
Days 1–2 (Tolerance)2.5 mg (2500 mcg)50 units (0.50 mL)
Days 3+ (Standard)5 mg (5000 mcg)100 units (1.00 mL)
Alternative BID2.5 mg twice daily50 units (0.50 mL) × 2
Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours, twice-daily (BID) dosing may provide more sustained NNMT inhibition. A single 10 mg vial provides 2–4 days of material at these doses.

Reconstitution Steps

  • 1. Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes.
  • 2. Draw 2.0 mL bacteriostatic water with a sterile syringe.
  • 3. Inject slowly down the vial wall; avoid foaming.
  • 4. Gently swirl/roll until dissolved—solution should be clear (do not shake).
  • 5. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.

Important: This guide is for educational purposes only and is not medical advice.

  • Supplies Needed
Plan based on protocol duration using the 10 mg vial format at 5 mg/day.
  • 5-Amino-1MQ Vials (10 mg each):
  • 1 week (5 mg/day = 35 mg total) : 4 vials
  • 2 weeks (5 mg/day = 70 mg total) : 7 vials
  • 4 weeks (5 mg/day = 140 mg total) : 14 vials
  • Insulin Syringes (U-100, 1 mL):
  • 1 week (once daily) 7 syringes
  • 2 weeks (once daily): 7 syringes (1/day)
  • 4 weeks (once daily): 28 syringes
  • Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
  • 1 week (4 vials × 2.0 mL = 8 mL): 1 × 10 mL bottles
  • 2 weeks (7 vials × 2.0 mL = 14 mL): 2 × 10 mL bottles
  • 4 weeks (14 vials × 2.0 mL = 28 mL): 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
  • 1 week (once daily): 14 swabs
  • 2 weeks (once daily): 28 swabs
  • 4 weeks (once daily): 56 swabs → recommend 1 × 100-count box
  • Protocol Overview
Concise summary of the research reference information for the 10 mg vial format.
  • Research Summary: 5-Amino-1MQ is studied for its interaction with NNMT pathways and related cellular research.
  • Research Information: This section provides educational reference information related to the 10 mg vial format.
  • Concentration Reference: Concentration information is provided for research documentation purposes.
  • Research Documentation: Available information may be referenced when documenting laboratory research details.
  • Storage Instructions

Proper storage preserves peptide quality and stability.

  • Storage Reference: Storage information is provided for educational and laboratory research documentation purposes.
  • Research Storage: Maintain storage conditions according to available stability information.
  • Handling Reference: Follow applicable laboratory storage requirements.
  • Important Notes

Practical considerations for research documentation and handling.

  • Maintain appropriate research documentation and follow applicable laboratory handling procedures.
  • Maintain consistent documentation practices when recording research observations and handling information.
  • Research observations may include recording compound-related characteristics and documented findings from available research information.
  • Maintain organized research documentation to support consistency in recorded information.
  • The 10 mg vial format information can be referenced when documenting research requirements and study materials.
  • How This Works

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule studied for its interaction with Nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme involved in nicotinamide metabolism and cellular research pathways. Research studies have investigated NNMT activity and its role in related biochemical processes.

Research involving NNMT inhibition has focused on understanding its relationship with nicotinamide metabolism and related cellular mechanisms. This information is provided for educational and research reference purposes only.

  • Research Observations

Observations from preclinical and early research literature related to 5-Amino-1MQ research.

  • Research studies have investigated 5-Amino-1MQ and its relationship with metabolic pathways in preclinical models.
  • Preclinical research has examined NNMT activity and related cellular mechanisms associated with 5-Amino-1MQ.
  • Research observations have explored the interaction between NNMT pathways and related biological processes in experimental models.
  • Available research information is limited, and further studies are required to understand safety considerations.
  • Long-term human safety data has not been established; this compound remains investigational.
  • Lifestyle Factors
Complementary strategies for best outcomes.
  • Pair with a balanced, protein-forward diet tailored to energy needs.
  • Combine resistance training and aerobic activity—preclinical data suggest synergy with exercise.
  • Prioritize sleep and stress management to support metabolic adaptation.
  • Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols.
  • Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Clean the vial stopper and injection site with alcohol; allow to dry completely.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Slow injection may minimize any stinging sensation associated with the compound.
  • Recommended Source
We recommend Vitality Labs Peptides for high-purity 5-Amino-1MQ (10 mg).

Why Vitality Labs Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
Contact on Telegram
  • Important Note

This content is intended for research and educational purposes only and does not constitute medical advice, diagnosis, or treatment.

  • References

Explore related research references and background information for 5-Amino-1MQ and NNMT research.

Nature Medicine (2014)

— Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity

More Info

PMC (2024)

— Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions

More Info

Frontiers in Pharmacology (2024)

— NNMT: a novel therapeutic target for metabolic syndrome
More Info

ResearchGate (2021)

— Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice
More Info

PMC (2022)

— Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice

More Info

Scientific Reports

— Research findings related to NNMT inhibition and cellular pathways

More Info

Journal of Medicinal Chemistry (ACS)

— Bisubstrate inhibitors of NNMT with enhanced activity
More Info
  • Table of Contents

5-Amino-1MQ Research Reference

5-Amino-1MQ research information is provided for educational and laboratory reference purposes. A 10 mg vial reconstituted with bacteriostatic water yields a concentration reference of approximately 5 mg/mL. This information is intended for research reference only and does not provide instructions for human use.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
  • Typical daily range: A 10 mg vial with 2.0 mL bacteriostatic water creates a concentration reference of approximately 5 mg/mL.
  • Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg (0.05 mg) on a U-100 insulin syringe.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.
5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 10 mg vial format.
  • Dosing & Reconstitution Guide
Subcutaneous, once or twice daily

Subcutaneous Protocol (2 mL = 5 mg/mL)

PhaseDaily Dose (mg)Units (per injection) (mL)
Days 1–2 (Tolerance)2.5 mg (2500 mcg)50 units (0.50 mL)
Days 3+ (Standard)5 mg (5000 mcg)100 units (1.00 mL)
Alternative BID2.5 mg twice daily50 units (0.50 mL) × 2
Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours, twice-daily (BID) dosing may provide more sustained NNMT inhibition. A single 10 mg vial provides 2–4 days of material at these doses.
Reconstitution Steps
  • 1. Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes.
  • 2. Draw 2.0 mL bacteriostatic water with a sterile syringe.
  • 3. Inject slowly down the vial wall; avoid foaming.
  • 4. Gently swirl/roll until dissolved—solution should be clear (do not shake).
  • 5. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.

Important: This guide is for educational purposes only and is not medical advice.

  • Supplies Needed
Plan based on protocol duration using the 10 mg vial format at 5 mg/day.
  • 5-Amino-1MQ Vials (10 mg each):
  • 1 week (5 mg/day = 35 mg total) : 4 vials
  • 2 weeks (5 mg/day = 70 mg total) : 7 vials
  • 4 weeks (5 mg/day = 140 mg total) : 14 vials
  • Insulin Syringes (U-100, 1 mL):
  • 1 week (once daily) 7 syringes
  • 2 weeks (once daily): 7 syringes (1/day)
  • 4 weeks (once daily): 28 syringes
  • Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
  • 1 week (4 vials × 2.0 mL = 8 mL): 1 × 10 mL bottles
  • 2 weeks (7 vials × 2.0 mL = 14 mL): 2 × 10 mL bottles
  • 4 weeks (14 vials × 2.0 mL = 28 mL): 3 × 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
  • 1 week (once daily): 14 swabs
  • 2 weeks (once daily): 28 swabs
  • 4 weeks (once daily): 56 swabs → recommend 1 × 100-count box
  • Protocol Overview
Concise summary of the subcutaneous regimen.
  • Goal: Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels.
  • Schedule: Daily subcutaneous injections; each 10 mg vial provides 2–4 days of material.
  • Dose Range: 2.5–5 mg once or twice daily.
  • Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate measurements.
  • Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).
  • Storage Instructions

Proper storage preserves peptide quality and stability.

  • Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months.
  • Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.
  • Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.
  • Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.
  • Do not refreeze reconstituted solution.
  • Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each administration; dispose in a sharps container.
  • Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
  • Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.
  • Document daily dose and site rotation to maintain consistency.
  • The 10 mg vial format requires multiple vials for extended protocols; plan supplies accordingly.
  • How This Works
5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT. NNMT is a cytosolic enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor. In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability.

By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis via the salvage pathway, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis, fat oxidation, and metabolic flexibility. Preclinical studies indicate that NNMT knockdown or inhibition can protect against diet-induced weight gain and improve metabolic parameters without reducing food intake.
  • Potential Benefits & Side Effects
Observations from preclinical and early research literature.
  • May support reductions in fat mass while preserving lean muscle in animal models.
  • Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies.
  • Enhanced grip strength observed in aged mice when combined with exercise.
  • Generally well tolerated; occasional reports of mild headache, transient jitteriness, or injection-site reactions.
  • Long-term human safety data not established; this compound remains investigational.
  • Lifestyle Factors
Complementary strategies for best outcomes.
  • Pair with a balanced, protein-forward diet tailored to energy needs.
  • Combine resistance training and aerobic activity—preclinical data suggest synergy with exercise.
  • Prioritize sleep and stress management to support metabolic adaptation.
  • Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols.
  • Injection Technique

General subcutaneous guidance from clinical best-practice resources.

  • Clean the vial stopper and injection site with alcohol; allow to dry completely.
  • Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue.
  • Do not aspirate for subcutaneous injections; inject slowly and steadily.
  • Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.
  • Slow injection may minimize any stinging sensation associated with the compound.
  • Recommended Source
We recommend Vitality Labs Peptides for high-purity 5-Amino-1MQ (10 mg).

Why Vitality Labs Peptides?

  • High-purity, third-party-tested lots with batch COAs.
  • Consistent, ISO-aligned handling and documentation.
  • Reliable fulfillment to maintain cold-chain integrity.
Contact on Telegram
  • Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

  • References

Explore related research dosage protocols and background reading for BPC-157 + TB-500.

Nature Medicine (2014)

— Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity
More Info

PMC (2024)

— Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions
More Info

Frontiers in Pharmacology (2024)

— NNMT: a novel therapeutic target for metabolic syndrome
More Info

Creative Peptides

— Peptide stability and storage guidelines for lyophilized compounds
More Info

PubMed (2021)

— Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review
More Info

PMC

— Subcutaneous drug injection review: pharmacologic considerations
More Info

NCBI Bookshelf

— Best practices for injection (asepsis, preparation, and administration)
More Info

ResearchGate (2021)

— Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice
More Info

PMC (2022)

— Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice
More Info

Scientific Reports / NMN.com

— Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise
More Info

Swolverine

— 5-Amino-1MQ mechanism, benefits, stacking and cycling guide
More Info

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration)
More Info

CDC (Subcut Injection PDF)

— Technique diagram and site guidance for subcutaneous injections
More Info

Journal of Medicinal Chemistry (ACS)

— Bisubstrate inhibitors of NNMT with enhanced activity
More Info

Vitality Lab Peptides

— 5-Amino-1MQ (10 mg) product page (quality and batch documentation)
More Info
  • Related Dosage Protocols

Explore related research dosage protocols and background reading for 5-Amino-1MQ.

5-Amino-1MQ (50 mg Vial) Dosage Protocol

Ipamorelin (10 mg Vial) Dosage Protocol

Semaglutide (5 mg Vial) Dosage Protocol

HCG (5000 IU Vial) Dosage Protocol